多伞阿魏抗胃癌活性部位的急性毒性试验研究

doi:10.19803/j.1672-8629.20230136

中国药物警戒 ›› 2023, Vol. 20 ›› Issue (8): 880-884.
DOI: 10.19803/j.1672-8629.20230136

多伞阿魏抗胃癌活性部位的急性毒性试验研究

杨明翰¹, 乔美玲^1,3, 骆骄阳², 杨美华², 盛萍^1,*

¹新疆医科大学中医学院,新疆乌鲁木齐 830011;
²中国医学科学院药用植物研究所,北京 100193;
³博尔塔拉蒙古自治州人民医院,新疆博乐 833400

收稿日期:2023-03-16 出版日期:2023-08-15 发布日期:2023-08-07
通讯作者: ^*盛萍,女,博士,教授·博导,中药民族药资源质量标准研究。E-mail: xjsphwy@163.com
作者简介:杨明翰,男,硕士,实验师,中药民族药资源质量标准研究。
基金资助:
国家自然科学基金资助项目（81560633）; 2017年自治区中药民族药特色技术传承人才项目（201727）

Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides

YANG Minghan¹, QIAO Meiling^1,3, LUO Jiaoyang², YANG Meihua², SHENG Ping^1,*

¹School of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi Xinjiang 830011, China;
²Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Beijing 100193, China;
³Bortala Mongolian Autonomous Prefecture People's Hospital, Bole Xinjiang 833400, China

Received:2023-03-16 Online:2023-08-15 Published:2023-08-07

摘要/Abstract

摘要： 目的研究多伞阿魏抗胃癌活性部位的急性毒性,初步评价多伞阿魏抗胃癌活性部位的安全性,为其抗胃癌药物研发与临床用药提供参考。方法采用最大给药量法给小鼠灌胃多伞阿魏抗胃癌活性部位混悬液;给药前和给药后第14天分别称量小鼠体重;连续14 d观察小鼠的一般状况和死亡情况;给药后第14天小鼠眼球取血,测定小鼠的白细胞数（WBC）、红细胞数（RBC）、血红蛋白浓度（HGB）、血小板数（PLT）及淋巴细胞百分比（LYM）;解剖小鼠,计算肝、脾、肾脏器指数;制作肝、脾、肾、胃组织病理切片,观察脏器病理损伤情况。结果多伞阿魏抗胃癌活性部位对小鼠的最大给药量为5.00 g·kg^-1,给药期间多伞阿魏抗胃癌活性部位给药组小鼠给药后出现精神萎靡、倦怠、竖毛、毛发血色暗淡、粪便较粘稠的情况,24 h后均恢复正常,其他一般状况未见异常。此外,在实验14 d内,与空白对照组比较,多伞阿魏抗胃癌活性部位给药组小鼠饮食和体重变化均无明显差异（P > 0.05）,WBC、RBC、HGB、PLT及LYM均未见统计学差异（P > 0.05）,小鼠肝、脾、肾脏器指数均未见统计学差异（P > 0.05）,组织病理结果显示,肝、脾、肾、胃未见明显的病理改变。结论在本实验条件下,多伞阿魏抗胃癌活性部位在14 d内未见严重毒性反应,对小鼠的体重、饮食无明显影响,对小鼠的肝、脾、肾、胃无显著影响,但在给药后2 h内出现一定程度的刺激反应,24 h后均可逐渐恢复正常,这可能是由于多伞阿魏抗胃癌活性部位的神经刺激或胃肠道刺激所导致的应激反应。

关键词: 多伞阿魏, 抗胃癌活性部位, 小鼠, 灌胃, 急性毒性

Abstract: Objective To study the acute toxicity and safety of anti-gastric cancer active ingredients of Ferula ferulaeoides so as to provide reference for the research and development of anti-gastric cancer drugs and clinical medications. Methods The mixed suspension of anti-gastric cancer active ingredients of Ferula ferulaeoides was administered intragastrically to mice at the maximum dose. The mice were weighed before and 14 days after administration. The health and death of mice were observed for 14 consecutive days. On the 14th day after administration, serum was collected, and the white blood cell count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), platelet count (PLT) and lymphocyte percentage (LYM) of mice were determined. The indexes of the liver, spleen and kidney were calculated by dissecting mice. The pathological sections of the liver, spleen, kidney and stomach were prepared to observe the pathological injury to the organs. Results The maximum dosage of anti-gastric cancer active ingredients of Ferula ferulaeoides for mice was 5.00 g·kg^-1. During administration, the mice in the group of anti-gastric cancer active ingredients of Ferula ferulaeoides appeared listless, tired, with erection and dark blood color of hair and sticky feces. Compared with blank control group, there was no significant difference in body weight before and 14 d after administration (P > 0.05), or in white blood cell count (WBC), red blood cell count (RBC), hemoglobin concentration (HGB), platelet count (PLT) and lymphocyte percentage (LYM) (P > 0.05), or in the indexes of the liver, spleen and kidney (P > 0.05). Histopathological results showed no significant pathological changes in the liver, spleen, kidney or stomach. Conclusion The anti-gastric cancer active ingredients of Ferula ferulaeoides cause no serious toxic reactions within 14 days, without any significant effect on the weight and diet of mice or on the liver, spleen, kidney and stomach of mice, but irritative reactions may occur within 2h of administration. This may be caused by nerve irritation or gastrointestinal irritation of the anti-gastric cancer active ingredients of Ferula ferulaeoides.

Key words: Ferula ferulaeoides, anti-gastric cancer active ingredients, mice, intragastrical administration, acute toxicity

中图分类号:

杨明翰, 乔美玲, 骆骄阳, 杨美华, 盛萍. 多伞阿魏抗胃癌活性部位的急性毒性试验研究[J]. 中国药物警戒, 2023, 20(8): 880-884.

YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping. Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884.

参考文献

[1] SHEN GM.Zhong Cao Yao Cong Shu: A Wei (中草药丛书: 阿魏)[M]. Urumqi: Xinjiang People's Publishing House, 1986.
[2] Xinjiang Institute of Biological Soil and Desert Research. Annals of Medicinal plants in Xinjiang (新疆药用植物志)[M]. Urumqi: Xinjiang People's Publishing House, 1977:106.
[3] SONG DW, ZHAO WJ, WU XP, et al.Study on chemical component of Ferula ferulaeoides[J]. Chinese Traditional and Herbal Drugs(中草药), 2006, 37(11): 1627-1629.
[4] SHENG P, TANG DP, MIAO LJ, et al.GC-MS fingerprints of essential oils of Ferula ferulaeoides from different habitats[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2015, 32(1): 30-37.
[5] MENG H, LI G, HUANG J, et al.Sesquiterpenoid derivatives from Ferula ferulaeoides (Steud.)Korov[J]. Phytochemistry, 2013, 86(2): 151.
[6] ZHANG L, TONG XP, ZHANG J, et al.DAW22, a natural sesquiterpene coumarin isolated from Ferula ferulaeoides (Steud.) Korov. that induces C6 glioma cell apoptosis and endoplasmic reticulum (ER) stress[J]. Fitoterapia, 2015, 103: 46-54.
[7] WANG S.Studies on the fingerprint of active site of gastric cancer in vitro of Xinjiang Ferula ferulaeoides[D]. Urumqi: Xinjiang Medical University, 2015.
[8] YE BE, LIU F, XION YJ, et al.Effects of Anti-inflammatory and immunosuppressive on three species of Ferula[J]. Northwest Pharmaceutical Journal(西北药学杂志), 1993, 8(2): 72-75.
[9] GAO TT, YU FH, TAN Y, et al.Study on antimicrobial activity in vitro of extracts from three species of Ferula root[J]. Food Science and Technology(食品科技), 2013(24): 156-158.
[10] YANG MH, LUO JY, QIAO ML, et al.Mechanism of Uygur medicine root of Ferula ferulaeoides in resisting gastric cancer activity and inducing cell apoptosis and cell cycle arrest in vitro[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2018, 24(10): 112-122.
[11] QIAO ML, LUO JY, YANG MH, et al.Effect of Ferula ferulaeoides on growth and apoptosis of human gastric cancer MGC-803 transplantation tumor in nude mice[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(13): 2827-2834.
[12] The research group of the project “Technical Guidelines for the study of acute toxicity of traditional Chinese medicine and natural drugs”. Technical guidelines for the study of acute toxicity of traditional Chinese medicine and natural drugs(中药、天然药物急性毒性研究技术指导原则)[S]. Beijing: Food and Drug Administration of the People's Republic of China, 2004.
[13] WANG R, LIU ZQ, WANG NN, et al.The study on acute toxicity test of anti-hypertensive new drug proline Danshensu borneol ester on mice[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(7): 754-757.
[14] MO ZH, CHEN MX, WANG PC, et al.Acute toxicity of Huoxin Pill in mice[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2021, 18(10):924-929.
[15] CHEN QS, CAI SF, TAN YF, et al.Acute toxicity of mangrove plant Lumnitzera racemosa extract on mice[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(2): 72-74, 86.
[16] XIONG YJ, LIU F, YE BE, et al.Effects of three species of Ferula on the gastroenteric tract[J]. Journal of Xinjiang Medical University(新疆医科大学学报), 1993(4): 300-302.

多伞阿魏抗胃癌活性部位的急性毒性试验研究

Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	孙绮悦, 赵荣华, 包蕾, 郭姗姗, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 基于多动物模型药效评价体系研究羚羊感冒口服液儿童用药剂量[J]. 中国药物警戒, 2024, 21(2): 121-126.
[2]	孙绮悦, 赵荣华, 郭姗姗, 包蕾, 耿子涵, 李舒冉, 徐英莉, 张敬升, 崔晓兰, 孙静. 羚羊感冒口服液多重药理作用研究[J]. 中国药物警戒, 2024, 21(2): 127-131.
[3]	赵荣华, 孙静, 包蕾, 耿子涵, 陶夏莉, 张敬升, 庞博, 徐英莉, 曹姗, 李舒冉, 郭姗姗, 王道涵, 崔晓兰. 基于免疫调节探讨葛根汤颗粒治疗小鼠病毒性肺炎的作用机制[J]. 中国药物警戒, 2024, 21(2): 132-136.
[4]	曹姗, 庞博, 徐英莉, 张敬升, 陈梦苹, 张宇, 王雅欣, 包蕾, 耿子涵, 郭姗姗, 赵荣华, 崔晓兰. 疏风解毒胶囊预防给药对流感病毒感染小鼠模型TLR4介导肺组织炎性损伤的影响[J]. 中国药物警戒, 2024, 21(1): 45-50.
[5]	张敬升, 高双荣, 庞博, 刘莉娜, 徐英莉, 曹姗, 陈梦苹, 张宇, 赵荣华, 崔晓兰. 散寒化湿颗粒对人冠状病毒229E和OC43感染致小鼠肺炎的作用机制研究[J]. 中国药物警戒, 2024, 21(1): 51-54.
[6]	张亮亮, 胡昌坤, 吴泽坤, 周维, 廖泽彬, 高月. 富马酸二甲酯对肠道辐射损伤防护作用及机制研究[J]. 中国药物警戒, 2024, 21(1): 83-88.
[7]	殷玉玲, 胡楚涓, 张晓朦, 王雨, 张冰, 林志健. 菊苣提取物抗阿霉素心脏毒性作用挖掘及验证[J]. 中国药物警戒, 2023, 20(8): 858-865.
[8]	梅雨, 朱越, 张慧婷, 肖成荣, 高月, 马增春. 基于网络药理学和实验验证探讨中药复方CB001对低剂量辐射防护的作用机制[J]. 中国药物警戒, 2023, 20(8): 872-879.
[9]	沈宁宁, 刘昱甫, 茹毅, 师卓, 杨春启, 倪喆鑫, 肖成荣, 马增春, 王宇光, 高月. 麦冬皂苷D对小鼠力竭游泳抗疲劳作用的研究[J]. 中国药物警戒, 2023, 20(7): 749-753.
[10]	王荣, 刘自群, 王娜娜, 谭雄, 张怡心, 杨宽, 秦蓓. 脯氨酸丹参素冰片酯对小鼠急性毒性研究[J]. 中国药物警戒, 2023, 20(7): 754-757.
[11]	左泽平, 田颖颖, 徐意, 姜克武, 杨硕, 杨海润, 张志聪, 曹欣垚, 吴笑如, 王志斌. 金匮肾气丸临床前安全性评价研究[J]. 中国药物警戒, 2023, 20(7): 775-782.
[12]	辛雨濛, 卢天公, 孙震晓. 甘草干姜汤对顺铂所致巨噬细胞毒性的保护作用[J]. 中国药物警戒, 2023, 20(6): 661-670.
[13]	刘欢, 袁慧, 尹晶晶, 刘梦雅, 秦秀军, 李建国. 薏芽健脾凝胶幼龄大鼠的一般毒理学研究[J]. 中国药物警戒, 2023, 20(4): 416-422.
[14]	赵荣华, 孙静, 包蕾, 耿子涵, 李贵平, 王道涵, 李舒冉, 张敬升, 庞博, 徐英莉, 周利润, 鲍岩岩, 陈梦苹, 郭姗姗, 崔晓兰. 金振口服液对人冠状病毒肺炎热毒疫幼龄小鼠模型的干预机制[J]. 中国药物警戒, 2023, 20(3): 248-252.
[15]	刘静, 王峰, 张靖溥, 孟杰, 戴忠, 马双成. 舒筋定痛片对斑马鱼胚胎发育的急性毒性研究[J]. 中国药物警戒, 2023, 20(3): 262-265.